Recent trends, technological advances, reimbursement scenario and initiatives at the international level

DUBLIN, May 9, 2022 /PRNewswire/ — The “Plasma Medicine Market – Strategies and Implementation” report has been added to from offer.

Research and Markets Logo

Research and Markets Logo

This strategic report provides a multidimensional view of the strategic evolution of ongoing plasma medicine initiatives. The objective of the study is to have a global vision of active plasma medicine projects implemented in several countries. The report contains the analysis of various trends such as recent trends, technological advancements, reimbursement scenario and international level initiatives across the globe influencing the adoption of plasma medicine.

Plasma medicine is a growing field combining plasma physics, biology and clinical medicine and has an impact in several important areas of therapeutic patient care, combining plasma physics, biology and clinical medicine. Previously, plasmas in medicine were used in non-contact hemostasis and electrosurgery for cauterization, while currently, non-thermal plasmas are widely used in medicine due to their efficiency and compatibility with biological systems.

The most active areas of plasma technology applications are inactivation of pathogens, treatment of wounds, treatment of skin conditions, tissue regeneration and sterilization. There are different ways to generate plasmas for use in medical applications, such as plasma jets, dielectric barrier discharges, capacitive or inductive coupled discharges, and microplasmas. These technologies transform systems that use ambient air, gases and other low temperature liquids.

In addition, several commercial products were reviewed in light of technology used, health issues addressed, and clinical trial results.

The scope of this report is centered on performing a detailed study of strategies, R&D best practices across the globe and understanding the direction of prominent stakeholders helping to increase the growth of Plasma Medicine initiatives .

Over the past decade, plasma medicine has become a rapidly growing multidisciplinary research topic of increasing importance that examines tremendous opportunities at the interface of chemistry, plasma physics and biomedical sciences with engineering due to both the development of low temperature plasma sources and a good understanding of complex plasma phenomena.

This premium market intelligence also highlights existing opportunities in the market, including the wide scope for the adoption of plasma medicine approach in emerging countries, the increased use of non-invasive tools and the providing a solution for the treatment of wound infection. The study is mainly centered on the sub-segments and micro-segments of the various products being marketed in the market.

To emphasize the dominance of North America segment in Regional Segmentation of Plasma Drugs Market in 2020 & 2031, Nitish Kumar Singh, senior analyst at the publisher, says Plasma Medicine holds immense potential to restructure the healthcare industry. It is an emerging approach that allows the study of infectious wound diseases by evaluating non-invasive treatment, thus offering a therapeutic treatment adapted to each patient.

Key insights are drawn from in-depth interviews with key opinion leaders from major companies, market players and vendors. The major players profiled in the report are US Medical Innovations, Plasmacure, neoplas med GmbH, Plasma Surgical, Coldplasmatech GmbH, and terraplasma medical GmbH.

How can plasma medicine business information add value to an organization’s decision-making process?

  • Offers detailed information on the future prospects of emerging and established players

  • Proposes go-to-market strategies for different types of sources

  • Helps diversify product portfolio based on risk and application progression

  • Offers tailor-made solutions according to the speed of different consumers

  • Helps understand technology requirements

  • Help to explore the new application

  • Assistance in the analysis of the financing scenario of competitors

  • Helps understand the involvement of government health organizations such as the United States Food and Drug Administration (US FDA)

  • Helps understand new industry trends

Insightful questions covered to enable businesses to make strategic decisions

  • What are the Plasma Drugs industry strategies and implementation that may affect the future perception of the market?

  • How is the market expected to grow over the coming period (5-10 years)?

  • How is plasma medicine evolving?

  • What are the main applications of plasma medicine?

  • What are the emerging technological trends in the plasma medicine market?

  • What are the key development strategies implemented by the major players to stay in the competitive market?

  • What are the key regulatory implications in developed and developing regions for the Plasma Drugs Market?

  • Who are the leading players with major deals in the plasma medicine market? What is the current market dominance for each of these major players?

  • What are the key technologies utilized in the Plasma Drugs market? What is the dominant technology?

  • Who are the major end users of the Plasma Drugs Market?

  • Who are the key players in the Plasma Drugs market and what are their contributions? Furthermore, what is the growth potential of each major manufacturer of Plasma Drugs market?

  • What is the Scope of the Plasma Drugs Market in North America, Europe, Asia Pacific, Latin America, and the rest of the world? Which plasma medicine technology and which end user dominates these regions?

  • What are the emerging trends in the plasma drugs market? How are these trends revolutionizing the treatment process?

  • What technologies are expected to break into the plasma-based drug market regime?

  • Which companies are expected to be highly disruptive in the future and why?

  • What regulatory procedures are needed to unify the approval process for the emerging plasma drug market? How will this improve the repayment scenario?

  • What are the gaps in regularizing the market adoption of plasma-based drugs in regular healthcare routines? How are these gaps filled?

Main topics covered:

1 Industry Overview

2 Timeline: Evolution of plasma medicine

2 An overview of plasma medicine

3 applications

3.1 Therapeutic applications

3.2 Biological decontamination

4 Risk assessment

5 Basic cell biology of plasma wound healing

6 Plasma Medicine Challenges and Prospects

7 Plasma Medicine Implementation Strategies (by Region)

7.1 North America

7.1.1 United States American medical innovations Products offered by the Company The Canady Cold Plasma Procedure

7.2 Europe

7.2.1 Netherlands Plasmacurus Product offered by the Company

7.2.2 Germany neoplas med GmbH Product offered by the Company Treatment of chronic wounds: mode of action of kINPen MED terraplasma medical GmbH Product offered by the Company coldplasmatech GmbH Product offered by the Company: CPT processing

7.2.3 Georgia Surgical Plasma Product offered by the Company

8 SWOT Analysis of Plasma Medicine

8.1 Strengths

8.2 Weaknesses

8.3 Opportunities

8.4 Threats

9 The Making of Plasma Medicine

9.1 Europe

9.1.1 Germany Trends in German innovation policy Plasma drugs become a more important method of treatment Strategic and organizational dilemmas and management issues: building trust, implementing strategy and managing stakeholders Political implications

10 recent news and information about plasma therapy

10.1 As a potential treatment for diabetic foot ulcers, cold plasma ionized gas could also kill the COVID-19 virus inside

10.2 Cold Plasma against Coronavirus

10.3 Melanoma immunotherapy could be improved by using a cold plasma patch

11 Competitive Benchmarking

11.1 American medical innovations

11.1.1 Company Overview

11.1.2 Role of US Medical Innovations in Plasma Medicine Market

11.1.3 SWOT Analysis

11.2 Plasmacurus

11.3 neoplas med GmbH

11.4 Surgical Plasma

11.5 Coldplasmatech GmbH

11.6 terraplasma medical GmbH

For more information on this report, visit

Media Contact:

Research and Markets
Laura Woodsenior

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716



Show original content: initiatives-301542417.html

SOURCE Research and Markets

Leave a Reply

Your email address will not be published. Required fields are marked *